ITI Pharma and Healthcare Fund Regular Growth

• Alpha 0.00%
• Beta 0.00
• Sharpe Ratio0.00
• Std Deviation 0.00%
• Tracking Error 0.00%

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

The ITI Pharma and Healthcare Fund Regular Growth has an AUM of 208.21 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.35%. The minimum investment in ITI Pharma and Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Lupin, Suven Pharmaceuticals & Apollo Hospitals Enterprise.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Insurance (Life).

Some of the similar funds are LIC MF Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, ITI Pharma and Healthcare Fund Regular Growth. ITI Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.